Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
Fri, 16 Apr 2021 16:34:23 EDT

  Today, the FDA revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.

Coronavirus (COVID-19) Update: April 16, 2021
Fri, 16 Apr 2021 15:31:27 EDT

  Coronavirus (COVID-19) Update: April 16, 2021

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer
Fri, 16 Apr 2021 12:01:54 EDT

  Today, the FDA approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.

FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19
Wed, 14 Apr 2021 12:48:54 EDT

  FDA releases guidance on how remote interactive evaluations will be requested by FDA and conducted for the duration of COVID-19 at drug facilities.

Coronavirus (COVID-19) Update: April 13, 2021
Tue, 13 Apr 2021 13:31:44 EDT

  Coronavirus (COVID-19) Update: April 13, 2021

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
Tue, 13 Apr 2021 07:52:20 EDT

  Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine

FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer
Fri, 09 Apr 2021 17:37:48 EDT

  FDA authorized marketing of the GI Genius, the first device that uses artificial intelligence based on machine learning to detect lesions in the colon in real time during a colonoscopy.

Coronavirus (COVID-19) Update: April 9, 2021
Fri, 09 Apr 2021 14:35:13 EDT

  The FDA recommends health care personnel and facilities transition from the use of decontaminated disposable respirators, and issues warning letters to two companies for selling unapproved products with fraudulent COVID-19 claims.

FDA Releases Action Plan for Reducing Exposure to Toxic Elements from Foods for Babies, Young Children
Thu, 08 Apr 2021 13:28:40 EDT

  FDA Releases Closer to Zero: An Action Plan for Reducing Exposure to Toxic Elements from Foods for Babies and Young Children

FDA Releases Investigation Report Following Fall 2020 Outbreak of E. coli O157:H7 Illnesses Linked to Leafy Greens
Tue, 06 Apr 2021 15:34:24 EDT

  FDA publishes investigation report into Fall 2020 outbreak of Shiga Toxin-Producing E. coli (STEC) O157:H7 illnesses linked to the consumption of leafy greens

Coronavirus (COVID-19) Update: April 6, 2021
Tue, 06 Apr 2021 15:02:37 EDT

  Coronavirus (COVID-19) Update: April 6, 2021

Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for the Symbiotica COVID-19 Self-Collected Antibody Test System
Tue, 06 Apr 2021 11:02:53 EDT

  The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Symbiotica COVID-19 Self-Collected Antibody Test System.

Coronavirus (COVID-19) Update: April 2, 2021
Fri, 02 Apr 2021 17:46:36 EDT

  Coronavirus (COVID-19) Update: April 2, 2021

Coronavirus (COVID-19) Update: FDA Makes Two Revisions to Moderna COVID-19 Vaccine Emergency Use Authorization to Help Increase the Number of Vaccine Doses Available
Thu, 01 Apr 2021 20:24:39 EDT

  The FDA announced two revisions regarding the number of doses per vial available for the Moderna COVID-19 Vaccine.

FDA is Investigating Reports of Infections Associated with Reprocessed Urological Endoscopes
Thu, 01 Apr 2021 11:40:37 EDT

  FDA announced it’s investigating medical device reports describing patient infections associated with reprocessing urological endoscopes used to view and access the urinary tract.

Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development
Wed, 31 Mar 2021 21:53:49 EDT

  FDA Continues to Advance Over-the Counter and Other Screening Test Development.

Coronavirus (COVID-19) Update: March 30, 2021
Tue, 30 Mar 2021 15:12:02 EDT

  Coronavirus (COVID-19) Update: March 30, 2021

FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings
Tue, 30 Mar 2021 11:45:22 EDT

  FDA announced the use of the Binx Health IO CT/NG Assay at point-of-care settings, such as in physician offices, community-based clinics, urgent care settings, outpatient health care facilities and other patient care settings, operating under a CLIA Waiver.

FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
Sat, 27 Mar 2021 09:43:36 EDT

  The FDA approved Abecma, the first cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy.

Coronavirus (COVID-19) Update: March 26, 2021
Fri, 26 Mar 2021 15:35:12 EDT

  Coronavirus (COVID-19) Update: March 26, 2021

Food and Drugs Administration--Recalls/Safety Alerts

Creative Foods Inc Issues Allergy Alert on Undeclared Hazelnut, Peanut And Barley (Gluten) In Two Coffee Substitute Gluten-Free Products
Sat, 17 Apr 2021 00:00:00 EDT

  April 17, 2021, Creative Foods Inc. of Prineville, Oregon is recalling two products, Bueno Coffee Substitute Creamy Hazelnut and Bueno Coffee Substitute Pecan Praline. They both may contain undeclared peanut, hazelnut, and/or barley (gluten). While any gluten-containing product can cause health prob

Lake Champlain Chocolates Voluntarily Recalls Mr. Goodtime Bunny With Best By Date 11/20/2021 for Undeclared Almonds
Thu, 15 Apr 2021 00:00:00 EDT

  Lake Champlain Chocolates (LCC) is issuing a public alert and a voluntary recall on a mis-labeled Mr. Goodtime Bunny with a Best By date of 11/20/21 that may have been purchased between 2/22/21-3/25/21. LCC is issuing this recall after a consumer reported that the product contained almonds, which we

Jose Madrid Salsa Issues a Voluntary Recall Due to an Undeclared Anchovy Allergen
Wed, 14 Apr 2021 16:08:00 EDT

  Jose Madrid Salsa in Zanesville, Ohio is voluntarily recalling its Strawberry Mild salsa, packaged in 13oz glass jars, due to an undeclared anchovy allergen.

Blount Fine Foods Voluntarily Recalls a Limited Amount (a Single Lot) of Lobster Bisque Due to Possible Undeclared Egg Allergen
Wed, 14 Apr 2021 00:00:00 EDT

  Blount Fine Foods announced that, in partnership with the FDA, it is voluntarily recalling a limited amount (a single lot—2,987 cases total) of 16 oz. Panera at Home Lobster Bisque due to potential contamination with an undeclared egg allergen. The recall is limited to 1 SKU of 16 oz. Panera at Home

Urgent: Torn & Glasser Recalls Dark Chocolate Espresso Beans Because of Undeclared Walnut Allergen
Tue, 13 Apr 2021 00:00:00 EDT

  Torn & Glasser of Los Angeles, CA is recalling 7464 units of dark chocolate espresso beans due to an undeclared allergen.

Snak King Corporation Issues Allergy Alert on Undeclared Milk Allergen in Trader Joe’s Restaurant Style White Corn Tortilla Chips - Expanded to Include 8/11/21 Code Date
Tue, 13 Apr 2021 00:00:00 EDT

  Snak King Corporation of City of Industry, CA is voluntarily recalling 9 ounce packages of “Trader Joe’s Restaurant Style White Corn Tortilla Chips” with a sell by date of 08/09/21 and 08/10/21 due to a potential of an undeclared milk allergen. People who have an allergy or sensitivity to milk may

Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
Sat, 10 Apr 2021 00:00:00 EDT

  Sanit Technologies LLC d/b/a Durisan announces a voluntary recall expansion of its Durisan Antimicrobial Hand Sanitizer, NonAlcohol products in various sizes listed to now include products that have not yet expired. The products are being recalled due to out of specification microbial contamination.

Voluntary Recall of Hostess® SnoBalls® Due to Undeclared Allergen
Sat, 10 Apr 2021 00:00:00 EDT

  Hostess Brands, LLC (“Hostess Brands”) has become aware that certain Hostess® SnoBalls® were inadvertently manufactured in the packaging for Hostess® Chocolate CupCakes and the packaging does not list “coconut,” an ingredient in SnoBalls®, as an allergen.

The J. M. Smucker Co. Issues Limited, Voluntary Recall of Two Lots of Meow Mix® Original Choice Dry Cat Food for Potential Salmonella Contamination
Fri, 09 Apr 2021 00:00:00 EDT

  Orrville, OH – The J. M. Smucker Co. today announced a limited, voluntary recall of two lots of Meow Mix® Original Choice Dry Cat Food (30LB bag) due to potential salmonella contamination. The Company has received no reports of pet illness or adverse reaction and has issued this recall out of an abu

NS NY Distributor Inc Issues Voluntary Nationwide Recall of Premium OrgaZen 7000 and Ginseng Power 5000 Due to Presence of Undeclared Sildenafil and/or Tadalafil
Thu, 08 Apr 2021 16:37:00 EDT

  NS NY Distributor Inc is voluntarily recalling all lots within expiry of Premium Orgazen 7000 and Ginseng Power 5000 capsules to the consumer level. FDA analyses has found the products to contain undeclared sildenafil and/or tadalafil. Sildenafil and tadalafil are known as phosphodiesterase (PDE-5)

Glutenull Bakery Issues Allergy Alert on Undeclared Milk in Goji Berries and Chocolate Cookies
Wed, 07 Apr 2021 00:00:00 EDT

  Glutenull Bakery of Port Coquitlam, BC, Canada is recalling Goji Berries and Chocolate Cookies 11oz/320g, because it may contain undeclared milk.

Yolo Studio Issues Voluntary Nationwide Recall of PremierZEN Extreme 3000, PremierZEN Black 5000, & Triple SupremeZEN Plus 3500 Due to the Presence of Undeclared Tadalafil
Mon, 05 Apr 2021 00:00:00 EDT

  Cliffside Park, NJ, Yolo Studio is voluntarily recalling all lots of PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 to the consumer level. FDA analysis has found the product to contain undeclared tadalafil. Tadalafil is ingredient known as a phosphodiesterase (PDE-5) in

HI-TECH Pharmaceuticals Issues Allergy Alert on Various APS Isomorph 28 Products and iFORCE Nutrition Mass Gainz Dietary Supplements Due to Possible Undeclared Milk, Eggs, Wheat and Soy
Sat, 03 Apr 2021 00:00:00 EDT

  Hi-Tech Pharmaceuticals. Inc. of Norcross, GA is recalling all lots of APS Nutrition Isomorph 28 flavors in a 2 lb jug because it contains undeclared milk, wheat & soy allergens. All lots of iForce Nutrition Mass Gainz Brown Sugar Maple Oatmeal Cookie in 4.85lb jugs and 10 lb bags is also being reca

A-S Medication Solutions Issues Voluntary Nationwide Recall of Acetaminophen Extra Strength Tablets Contained in Health Essentials Kits Due to Mislabeling
Fri, 02 Apr 2021 00:00:00 EDT

  Libertyville, IL, A-S Medication Solutions, LLC (ASM) is voluntarily recalling 198,350 bottles of Acetaminophen Extra Strength 500 mg Tablets, 100 ct. bottles (NDC# 50090-5350-0) contained in Health Essentials Kits distributed by Humana to its members. See the photo below. This recall is being con

Rise Baking Company LLC Issues a Recall for Undeclared Hazelnut in Cakes
Wed, 31 Mar 2021 09:00:00 EDT

  Rise Baking Company of York, PA is recalling its Harris Teeter Brand 8” 3-layer Cookies and Creme Cake and Dawn Food Products Brand 7” 2-layer Vanilla Bean Waterfall Cake due to incorrect allergen labeling on the product. The product label does not list Hazelnut.

Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg Due to Trace Amounts of Quetiapine Fumarate
Wed, 31 Mar 2021 00:00:00 EDT

  Weston, Florida, Apotex Corp is voluntarily recalling three (3) lots of Guanfacine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine Fumarate in one lot RX1663. Out of an abundance of caution, lots RX1662 and RX1664 are also included in the scope of this voluntary

QMART Issues Voluntary Nationwide Recall of IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 Due to Presence of Undeclared Sildenafil and/or Tadalafil
Wed, 31 Mar 2021 00:00:00 EDT

  Elmwood Park, NJ, QMART is voluntarily recalling all lots of IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 to the consumer level. FDA analysis has found the products to be tainted with undeclared sildenafil and/or tadalafil. Sildenafil and tadalafil a

NANA Collection LLC Issues Voluntary Nationwide Recall of PremierZen Platinum 5000 & Triple SupremeZen Gold 3500 Due to Presence of Undeclared Drug Tadalafil and Sildenafil
Tue, 30 Mar 2021 11:23:00 EDT

  NANA Collection LLC is voluntarily recalling all lots of PremierZen Platinum 5000 and Triple SupremeZen Gold 3500 to the consumer level. FDA analysis has found the PremierZen Platinum 5000 to contain undeclared Tadalafil and Triple SupremeZen 3500 to contain undeclared Tadalafil and Sildenafil. Sild

Ummzy LLC Issues Voluntary Nationwide Recall of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night Due to the Presence of Undeclared Tadalafil Sildenafil & Vardenafil
Tue, 30 Mar 2021 00:00:00 EDT

  Palisades Park, NJ, Ummzy LLC is voluntarily recalling all lots of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Nightcapsules to consumer level. FDA analysis has found the product to contain undeclared tadalafil sildenafil & Vardenafil. Tadalafil, Sildenafil & Vardenafil are ingredientsknown as

Nuri Trading LLC Issues Voluntary Nationwide Recall of Shogun-X 7000, Thumbs Up 7 (Black) 25K, Thumbs Up 7 (White) 11K, 69MODE Blue 69, Due to the Presence of Undeclared Tadalafil, Sildenafil, and/ or Vardenafil
Mon, 29 Mar 2021 00:00:00 EDT

  Nuri Trading is voluntarily recalling all lots within expiry of Shogun-X 7000, Thumbs Up 7 (Black) 25K, Thumbs Up 7 (White) 11K, and 69MODE Blue 69 capsules to the consumer level.FDA analyses have found these products to contain undeclared tadalafil, sildenafil, and/orvardenafil.Sildenafil,tadalafil

What's New: Drugs RSS Feed

Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
Fri, 16 Apr 2021 22:49:58 EDT

  Sanit Technologies LLC d/b/a Durisan announces a voluntary recall expansion of its Durisan Antimicrobial Hand Sanitizer, NonAlcohol products in various sizes listed to now include products that have not yet expired. The products are being recalled due to out of specification microbial contamination.

Durisan Hand Sanitizer Recall Due to Microbial Contamination
Fri, 16 Apr 2021 16:53:27 EDT

  Sanit Technologies LLC d/b/a Durisan announces a voluntary recall of the lots listed in the table below of Durisan Antimicrobial Hand Sanitizer, Non-Alcohol products in various sizes listed. The products are being recalled due to microbial contamination. Specifically, out of specification results fo

Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
Fri, 16 Apr 2021 16:34:23 EDT

  Today, the FDA revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.

User Fee Lists
Fri, 16 Apr 2021 16:17:10 EDT

  Fiscal Year (FY) 2017 GDUFA facility fees are due on October 3, 2016.

Public Notification: Triple SupremeZen Plus 3500 contains hidden drug ingredient
Fri, 16 Apr 2021 16:01:31 EDT

  The Food and Drug Administration is advising consumers not to purchase or use SupremeZen Plus 3500, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Triple SupremeZen Extreme 3500 contains hidden drug ingredients
Fri, 16 Apr 2021 15:48:57 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Triple SupremeZen Extreme 3500, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Thumbs Up 7 Blue 69K contains hidden drug ingredients
Fri, 16 Apr 2021 15:45:58 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Thumbs Up 7 Blue 69K, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Thumbs Up 7 White 11K contains hidden drug ingredients
Fri, 16 Apr 2021 15:44:27 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Thumbs Up 7 White 11K, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Thumbs Up 7 Black 25K contains hidden drug ingredient
Fri, 16 Apr 2021 15:38:26 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Thumbs Up 7 Black 25K, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Shogun-X Platinum 7000 contains hidden drug ingredients
Fri, 16 Apr 2021 15:35:22 EDT

  The Food and Drug Administration is advising consumers not to purchase or Shogun-X Platinum 7000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Rock Steady 72 Hours contains hidden drug ingredients
Fri, 16 Apr 2021 15:31:51 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Rock Steady 72 Hours, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Coronavirus (COVID-19) Update: April 16, 2021
Fri, 16 Apr 2021 15:31:27 EDT

  Coronavirus (COVID-19) Update: April 16, 2021

Public Notification: Premier Platinum 5000 contains hidden drug ingredient
Fri, 16 Apr 2021 15:29:05 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Premier Platinum 5000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: PremierZen Extreme 3000 contains hidden drug ingredient
Fri, 16 Apr 2021 15:26:21 EDT

  The Food and Drug Administration is advising consumers not to purchase or use PremierZen Extreme 3000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

What's New Related to Drugs
Fri, 16 Apr 2021 15:25:20 EDT

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Public Notification: Original White Dragon contains hidden drug ingredients
Fri, 16 Apr 2021 15:23:06 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Original White Dragon, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Krazy Night contains hidden drug ingredient
Fri, 16 Apr 2021 15:20:30 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Krazy Night, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Kopi Jantan Tradisional Natural Herbs Coffee contains hidden drug ingredient
Fri, 16 Apr 2021 15:17:48 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Kopi Jantan Tradisional Natural Herbs Coffee, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Imperial Platinum 2000 contains hidden drug ingredient
Fri, 16 Apr 2021 15:13:57 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Imperial Platinum 2000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Public Notification: Imperial Gold 2000 contains hidden drug ingredients
Fri, 16 Apr 2021 15:11:16 EDT

  The Food and Drug Administration is advising consumers not to purchase or use Imperial Gold 2000, a product promoted and sold for sexual enhancement on various websites, including Amazon.com, and possibly in some retail stores.

Whats New Vaccines Blood Biologics RSS Feed

ANAVIP
Fri, 16 Apr 2021 17:18:19 EDT

  Product approval information is indicated for the management of adult and pediatric patients with North American rattlesnake envenomation.

What’s New for Biologics
Fri, 16 Apr 2021 17:17:44 EDT

  Latest news from the Center for Biologics Evaluation and Research

COVID-19 Vaccines
Fri, 16 Apr 2021 16:46:36 EDT

  FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

Learn More About COVID-19 Vaccines From the FDA
Fri, 16 Apr 2021 16:18:25 EDT

  Get answers to your questions about the standards for safety and effectiveness to support an emergency use authorization of COVID-19 vaccines.

Janssen COVID-19 Vaccine
Fri, 16 Apr 2021 16:05:57 EDT

  Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

Coronavirus (COVID-19) Update: April 16, 2021
Fri, 16 Apr 2021 15:31:27 EDT

  Coronavirus (COVID-19) Update: April 16, 2021

Patient Listening Session Summaries
Fri, 16 Apr 2021 15:02:47 EDT

  Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

What happens after a Patient Listening Session?
Fri, 16 Apr 2021 13:35:28 EDT

  Learn about what happens after a Patient Listening Session occurs and check out summaries from previous sessions on our website.

How does FDA benefit from Patient Listening Sessions?
Fri, 16 Apr 2021 12:04:55 EDT

  Learn how FDA benefits from Patient Listening Sessions, such as understanding what is important to patients, caregivers, and patient advocates when medical products are being developed.

Transfusion/Donation Fatalities
Fri, 16 Apr 2021 08:36:51 EDT

  This page provides details on the Notification Process for Transfusion Related Fatalities and Donation Related Deaths.

FDA Voices on Medical Products
Thu, 15 Apr 2021 17:25:36 EDT

  FDA Voices on Medical Products

FDA Voices
Thu, 15 Apr 2021 17:21:54 EDT

  Insights from FDA leadership and experts into the agency's work on policy, consumer safety & enforcement, medical products, food, & tobacco.

Bacterial Vaccine Safety: Biomarkers of Virulence and Attenuation in Bordetella Pertussis (Whooping Cough) and Anthrax Bacteria
Thu, 15 Apr 2021 10:35:36 EDT

  A description of E. Scott Stibitz's research program and related publications.

Evaluating Viral Antigens and Antibody Neutralization for HIV/AIDS, Smallpox, and Influenza
Thu, 15 Apr 2021 10:22:43 EDT

  A description of Carol Weiss's research program and related publications.

Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement - 04/15/2021 - 04/15/2021
Thu, 15 Apr 2021 07:49:41 EDT

  This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee April 15, 2021 Meeting Announcement.

Vaccines Research
Wed, 14 Apr 2021 17:47:40 EDT

  List of Vaccines Research.

Tissue & Advanced Therapies Research
Wed, 14 Apr 2021 17:22:40 EDT

  This page is about Tissue & Advanced Therapies Research

Workshops, Meetings & Conferences (Biologics)
Wed, 14 Apr 2021 13:48:18 EDT

  Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

Model Informed Drug Development Approaches for Immunogenicity Assessments - 06/09/2021 - 06/09/2021
Wed, 14 Apr 2021 13:36:08 EDT

  The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), in collaboration with the Center for Drug Evaluation and Research (CDER), are announcing the following public workshop entitled “Model Informed Drug Development Approaches for Immunogenicity Assessments.”

Janssen COVID-19 Vaccine Frequently Asked Questions
Wed, 14 Apr 2021 13:06:42 EDT

  Answers to frequently asked questions about FDA's Emergency Use Authorization of the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson



Here are some headlines supporting the benefits of a system like ADERS ®:



See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.






Products



 
 

Services




Contact Us


About PCS


Corporate Headquarters


Practical Compliance Solutions
One Orient Way
Suite F156
Rutherford, NJ 07070
  201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2021 - Copyright Practical Compliance Solutions - All rights reserved